BuPROPion Hydrochloride Tablets — Class II drug recall D-0328-2023
Terminated recall by Amerisource Health Services LLC, reported 2023-02-22, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0328-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amerisource Health Services LLC, Columbus, OH, United States |
| Recall initiated | 2022-12-27 |
| Classified | 2023-02-16 |
| Reported by FDA | 2023-02-22 |
| Terminated | 2023-08-04 |
| Distributed | Nationwide (US) |
| Quantity | 1,416 cartons |
| Reason classes | specification failure |
| NDC | 60687-0340, 60687-0340-01, 60687-0340-11, 60687-0351, 60687-0351-01, 60687-0351-11 |
| Lot numbers | 1003837 |
| Expiration dates | 2023-01-31 |
Product
BuPROPion Hydrochloride Tablets, USP 75 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-340-01; NDC Blister Pack: 60687-340-11
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0328-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.